Sign in
8-K

Current Report

X4 Pharmaceuticals, Inc Filed Acc 0001628280-22-024161

Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results

  • Item 3.03 Material modification to rights of security holders
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading xfor-20220901.htm…